[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
May 21, 1949

USE OF A SYMPATHOLYTIC DRUG (PRISCOL®)From the Point of View of a General Surgical Practitioner

JAMA. 1949;140(3):272-276. doi:10.1001/jama.1949.02900380012003

During the past few years, interest in and investigation of the sympathetic nervous system has rivaled that of the field of antibiotics. Much has been done and written concerning the physiology and pharmacology of alteration in sympathetic function, either by surgical procedure or by drugs.

However, most of the work previously reported has come from large hospital centers where facilities for investigational work and where routines of treatment can be easily established. The time has come, though, where the practical widespread use of these methods must be determined, since the manufacturers of various sympatholytic agents are making them available commercially. The medical profession has asked the question often as to how these agents might be used in everyday practice and which of the agents can be dispensed in the usual office or hospital practice with safety.

The ideal sympatholytic agent, from the point of view of the general medical or

First Page Preview View Large
First page PDF preview
First page PDF preview